Various salvage regimens have been used for relapsed/refractory EBV-HLH, including combination chemotherapy regimens, monoclonal antibodies targeting the host cellular reservoirs for EBV, and targeted agents aimed at controlling the systemic inflammatory syndrome that defines the disease pathophysiology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |